Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

IDRA 3.49 -0.02 (-0.57%)
price chart
Idera Pharmaceuticals: A Star In The Making (IDRA)
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) is a biotechnology company engaged in discovering and developing Toll-Like Receptors (TLRs) antagonists, novel-synthetic DNA and RNA based drug candidates.
Related articles »  
Idera Pharmaceuticals Going Into 2015 (IDRA)
Idera Pharmaceuticals Inc. (NASDAQ:IDRA) is set to enter 2015 with a number of important developments happening during the year.
Related articles »  
Idera Pharmaceuticals Inc. (IDRA) is Trading Lower on Unusual Volume for ...
Idera Pharmaceuticals Inc. ($IDRA) experienced unusually high volume on Mar. 25, as the stock lost 11.81% to a closing price of $3.51.
Idera Pharmaceuticals (IDRA) In A Perilous Reversal
Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States.
Stock to Follow: Idera Pharmaceuticals Inc (NASDAQ:IDRA)  Markets Wired
5 Stock in Different Moves: LKQ Corp. (NASDAQ:LKQ), Idera Pharmaceuticals ...  Property Mentor
Idera Pharmaceuticals, Inc. Short Interest Disclosure
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) encountered a drop of 2.3% or -223,579 shares in the short positions. The number dropped from 9,670,094 on February 13,2015 to 9,446,515 on February 27,2015.
Idera Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial ...  MarketWatch
Idera Pharmaceuticals Inc (NASDAQ:IDRA) on Watch
[Globe Newswire] Idera Pharmaceuticals Inc (NASDAQ:IDRA) (TREND ANALYSIS), announced the closing of its previously announced underwritten public offering of 23,000,000 shares of common stock at an offering price of $3.75 per share.
Company Shares of Idera Pharmaceuticals, Inc. Drops by -3.9%  Ashburn Daily
Major Falls in Review -Idera Pharmaceuticals (IDRA), Autohome (ATHM ...  Investor Wired
Idera Pharmaceuticals Inc (NASDAQ:IDRA) in Spotlight
[Globe Newswire] Idera Pharmaceuticals Inc (NASDAQ:IDRA) (TREND ANALYSIS), announced the pricing of an underwritten public offering of 20,000,000 shares of common stock for a public offering price of $3.75 per share.
Share Price of Idera Pharmaceuticals Inc Rally 1.99%  Ashburn Daily
Biotech Stocks Volume Actives - Gilead Sciences, (NASDAQ:GILD), Idera ...  wsnewspublishers
Yesterday Stock's Downfall Alert - Weight Watchers International, (NYSE:WTW ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA), declined -5.02%, and closed at $3.97. The company holds the market capitalization of $492.55M.
Investors Dumping 4 Biotech Stocks - RXi Pharmaceuticals (RXII), Idera ...
RXi Pharmaceuticals Corp (NASDAQ:RXII) fell -11.24% to close last trading session at $0.790. The company, on March 23, 2015, declared at the annual meeting of the American Academy of Dermatology in San Francisco, several significant advancements ...
Stock Watch: Idera Pharmaceuticals Inc (NASDAQ:IDRA)
[Globe NewsWIRE] Idera Pharmaceuticals Inc (NASDAQ:IDRA) (TREND ANALYSIS), a clinical-stage biopharmaceutical company developing immune-modulating and gene silencing therapies for cancer and rare diseases, today announced the appointments ...